CANCER RESEARCH | COMMITTEE |
DATE |
TESTIMONY |
|
The House Energy and Commerce Subcommittee on Health |
6/2/04 |
Scientific Opportunities and Public Needs: Balancing NIH's Priority Setting Process
Dr. Andrew C. von Eschenbach, Director, National Cancer Institute, testified.
The witness provided oral testimony and NCI was not asked to provide a written statement at the hearing. Therefore no written testimony is available for this hearing.
|
|
The House Energy and Commerce Subcommittee on Oversight and Investigations |
5/18/04 |
NIH Ethics Concerns: Consulting Arrangements and Outside Awards
The NCI witnesses at this hearing were Dr. Lance A. Liotta, Chief of the Laboratory of Pathology; Dr. J. Carl Barrett, Director, Center for Cancer Research; and Dr. Anna D. Barker, Deputy Director for Advanced Technologies & Strategic Partnerships.
The witnesses provided oral testimony and NCI was not asked to provide written statements at either hearing. Therefore no written testimony is available for these hearings.
|
|
House Committee on
Government Reform, Subcommittee on Wellness and Human
Rights |
5/13/04 |
Delivering More Innovative and Effective Treatments to Make Cancer a More Treatable Disease
Statement of Michaele Chamblee Christian, M.D., Associate Director, Division of Cancer Treatment and Diagnosis, Cancer Evaluation Therapy Program, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services |
|
House Committee on Government Reform,
Subcommittee on Criminal Justice, Drug Policy and Human Resources
|
3/11/04 |
National Cancer Institute Research on Human Papillomavirus and Cervical Cancer
Statement of Edward Trimble, M.P.H., Cancer Evaluation Therapy Program, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services
|
|
House Committee on
Government Reform, Subcommittee on Wellness and Human
Rights |
11/13/03 |
Statement of Robert N. Hoover, M.D., Sc.D.
Director, Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services |
|
House Committee on
Government Reform, Subcommittee on Wellness and Human
Rights |
9/10/03 |
Research
on SV 40 Exposure and the Development of Cancer Statement of
James Goedert, M.D., Chief, Viral Epidemiology Branch, Division of
Cancer Epidemiology and Genetics, National Cancer
Institute |
|
House Committee on
Energy and Commerce, Subcommittee on Health |
7/10/03 |
NIH:
Moving Research from the Bench to the Bedside Statement of
Anna D. Barker, Ph.D., Deputy Director for Strategic Scientific
Initiatives, National Cancer Institute |
|
House Committee on
Government Reform |
6/3/03 |
The
Science of Potential Reduced Risk Tobacco Products Statement
of Scott J. Leischow, Ph.D., Chief, Tobacco Control Research Branch,
National Cancer Institute |
|
Senate Cancer
Coalition |
6/17/03 |
Research
on Molecular Targets to Diagnose, Prevent and Treat
Cancer Statement of J. Carl Barrett, Ph.D., Director, Center
for Cancer Research, National Cancer Institute |
|
Senate Cancer
Coalition |
3/31/03 |
Cancer
Survivorship: Moving the Science and Art of Research and Care Beyond
Cure Statement of Julia H. Rowland, Ph.D., Director, Office
of Cancer Survivorship, Division of Cancer Control and Population
Sciences, National Cancer Institute |
|
Senate Committee on
Appropriations Subcommittee on Labor, Health and Human Services,
Education, and Related Agencies and the Committee on Health,
Education, Labor and Pensions, Subcommittee on Public
Health |
2/28/02 |
Mammography Statement
of Andrew von Eschenbach, M.D., Director, National Cancer
Institute |
|
Senate Appropriations
Subcommittee on Labor, Health and Human Services, Education, and
Related Agencies |
6/21/01 |
Leukemia,
Lymphoma, and Multiple Myeloma: Toward a New
Understanding Richard Klausner, M.D., Director, National
Cancer Institute |
|
Senate Committee on
the Environment and Public Works |
6/11/01 |
The
Environment, Genes, and Cancer Deborah Winn, Ph.D., Acting
Associate Director, Epidemiology and Genetics Research Program,
Division of Cancer Control and Prevention |
|
Senate Cancer
Coalition |
6/5/01 |
Role of
the National Cancer Institute in Addressing Cancer
Clusters Robert Hoover, M.D., Sc.D., Director, Epidemiology
and Biostatistics Program;Accompanied by Susan Devesa, Ph.D.,
Chief, Descriptive Studies Section, Epidemiology and Biostatistics
Program |
|
Senate Appropriations
Subcommittee on Labor, Health and Human Services, Education, and
Related Agencies |
5/9/01 |
New
Directions in Breast Cancer Research Richard Klausner, M.D.,
Director, NCI |
|
House Committee on
Government Reform |
9/25/00 |
Ethnic
Minority Disparities in Cancer Treatment: Why the Unequal
Burden? Harold Freeman, M.D., Director, Center to Reduce
Cancer Health Disparities, NCI |
|
House Committee on
Government Reform |
6/7/00 |
Integrative
Oncology: Cancer Care for the Next Millenium Dr. Robert
Wittes, Deputy Director of Extramural Science and Director, Division
of Cancer Treatment and Diagnosis, NCI |
|
House Committee on
Government Reform |
9/23/99 |
Prostate
Cancer Research at the National Cancer Institute Richard
Kaplan, M.D., Senior Investigator, Cancer Therapy Evaluation
Program, NCI |
|
Senate Cancer
Coalition |
9/16/99 |
Cancer
Care in The United States: What's Right, What's Wrong? Ensuring the
Quality of Cancer Care Robert Hiatt, M.D., Ph.D., Deputy
Director of the Division of Cancer Control and Population
Sciences |
|
Senate Appropriations
Subcommittee on labor, Health and Human Services, Education and
Related Agencies |
6/16/99 |
Planning
for Prostate Cancer Research: Expanding the Framework and
Professional Judgment Estimates Richard D. Klausner,
M.D., Director, National Cancer Institute, and Harold Varmus, M.D.,
Director, National Institutes of Health |
|
House Committee on
Government Reform |
6/10/99 |
The Role
of Complementary and Alternative Medicine in the Detection and
Treatment of Women's Cancers Edward L. Trimble, Head,
Surgery Section, Division of Cancer Treatment and
Diagnosis |
|
Senate Appropriations
Subcommittee on Labor, Health and Human Services, Education and
Related Agencies |
1/21/99 |
The
Unequal Burden of Cancer: NCI Response to a Report by
the Institute of Medicine Richard Klausner, MD, Director,
NCI |
|
Senate Committee on
Governmental Affairs Permanent Subcommittee on
Investigations |
9/16/98 |
NCI
Management of Radiation Studies Richard Klausner, MD,
Director, NCI |
|
House Government
Reform and Oversight Committee |
7/31/98 |
On the
Status of the Integration of Complementary and Alternative Medicine
(CAM) and Cancer Richard Klausner, MD, Director,
NCI |
|
Subcommittee on Health
and Environment |
7/20/98 |
The
State of Cancer Research Edison Liu, M.D., Director,
Division of Clinical Sciences, accompanied by Dr. Steven Rosenberg,
M.D., Ph.D., Chief of Surgery |
|
Senate Cancer
Coalition |
7/16/98 |
Cancer
Treatments for the 21st Century Edison Liu, M.D., Director,
Division of Clinical Sciences |
|
Congressional Caucus
for Women's Issues |
4/30/98 |
Breast
Cancer Prevention Trial Leslie Ford, M.D. Associate Director
for Early Detection and Community Oncology, NCI |
|
Senate Appropriations
Subcommittee on Labor, HHS, & Related Agencies |
4/21/98 |
Breast
Cancer Prevention Trial Richard Klausner, MD, Director,
NCI |
|
Senate Appropriations
Subcommittee on Labor, HHS, & Related Agencies |
10/1/97 |
Estimated
Exposures and Thyroid Doses Received by the American People from
Iodine-131 in Fallout Following the Nevada Atmospheric Nuclear Bomb
Tests Richard Klausner, MD, Director,
NCI |
|
Senate Appropriations
Subcommittee on Labor, HHS, & Related Agencies |
6/19/97 |
Progress
Against Cancer Richard Klausner, MD, Director,
NCI |
|
Senate Appropriations
Subcommittee on Labor, HHS, & Related Agencies |
5/7/97 |
Advances
in Cancer Research
|
|
Senate Cancer
Coalition |
3/6/97 |
Environmental
Risk Factors and Cancer Susan Sieber, PhD,
NCI |
|
Senate Appropriations
Subcommittee on Labor, HHS, & Related Agencies |
2/5/97 |
Mammography
Screening for Women Ages 40-49 Richard Klausner, MD,
Director, NCI |
|
Senate Cancer
Coalition |
6/13/96 |
Bone Marrow
Transplantation for Breast Cancer Jeffrey Abrams, MD,
NCI |
|
Senate Committee on
Labor & Human Resources |
3/6/96 |
Cancer,
Genetics, and the Environment Francis Collins, MD, PhD, Director, NIHGR;
Richard Klausner, MD, Director, NCI; and Kenneth Olden, PhD,
Director, NIEHS |
APPROPRIATIONS | COMMITTEE | DATE | TESTIMONY |
| Senate Subcommittee on Labor-HHS-Education Appropriations | 4/1/04 | Fiscal Year 2005 Budget Request Andrew C. von Eschenbach, M.D., Director, National Cancer Institute; William Beldon, Acting Deputy Assistant Secretary, Budget |
|
Senate Subcommittee on
Labor-HHS-Education Appropriations |
4/8/03 |
Fiscal
Year 2004 Budget Request Andrew C. von Eschenbach, M.D.,
Director, National Cancer Institute; Willam R. Beldon, Acting Deputy
Assistance Secretary for Budget, DHHS; Kerry N. Weems, Acting
Assistant Secretary for Budget, Technology and
Finance |
|
House Appropriations Subcommittee
on Labor-HHS-Education |
3/13/02 |
Fiscal
Year 2003 Budget Request Andrew C. von Eschenbach, M.D.,
Director, National Cancer Institute; Kerry N. Weems, Acting
Deputy Assistant Secretary for Budget, Department of Health and
Human Services |
|
|
Senate Appropriations
Subcommittee on Labor, HHS, Education, and Related
Agencies |
5/23/01 |
Statement
of the NCI Director for Fiscal Year 2002 President's Budget
Request Richard Klausner, MD, Director, NCI |
|
|
House Subcommittee on
Labor-HHS-Education Appropriations |
5/16/01 |
Statement
of the NCI Director on the Fiscal Year 2002 President's Budget
Request Richard Klausner, MD, Director, NCI |
|
|
Senate Appropriations
Subcommittee on Labor, HHS, Education, and Related
Agencies |
3/30/00 |
Statement
of the NCI Director for Fiscal Year 2001 Richard Klausner,
MD, Director, NCI |
|
|
House Appropriations Subcommittee
on Labor, Health and Human Services, and Education |
2/15/00 |
Statement
of the NCI Director for Fiscal Year 2001 Richard Klausner,
MD, Director, NCI |
|
|
House Appropriations
Subcommittee on Labor, Health and Human Services, and
Education |
2/24/99 |
Statement
of the NCI Director for Fiscal Year 2000 Richard Klausner,
MD, Director, NCI |
|
Senate Appropriations
Subcommittee on Labor, HHS, Education, and Related
Agencies |
2/23/99 |
Statement
of the NCI Director for Fiscal Year 2000 Richard Klausner,
MD, Director, NCI |
|
House & Senate
Appropriations Subcommittees on Labor, HHS, & Related
Agencies |
3/25/98 |
Statement of the NCI
Director for Fiscal Year 1999 Richard Klausner, MD, Director,
NCI |
|
House & Senate
Appropriations Subcommittees on Labor, HHS, & Related
Agencies |
2/97 |
Statement
of the NCI Director for Fiscal Year 1998 Richard Klausner,
MD, Director, NCI |